Marc Becker Net Worth & Insider Trades

Marc Becker - Chief Financial Officer, Concert Pharmaceuticals, Inc

As of February 16, 2022

What is Marc Becker's Net Worth?

The current estimated net worth of Concert Pharmaceuticals, Inc's Chief Financial Officer, Marc Becker, is estimated to be about $364.19K . Marc Becker owns about 139,011 units of Concert Pharmaceuticals, Inc common stock. In the last 3 years at Concert Pharmaceuticals, Inc, Marc Becker has sold an estimated value of $101.79K worth.

What is Marc Becker's Past Insider Trading?

Marc Becker's largest sale order was 2,875 units , worth over $29.44K on August 19, 2020. In total, Marc Becker has made about 9 transactions over 3 years of their time at Concert Pharmaceuticals, Inc. Marc Becker usually trades in February, January and August, with the busiest year in 2021 and 2022. The most recent transaction was a sale order of 3,762 units , worth over $11.59K on February 16, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Marc Becker's' Mailing Address?

  • Mailing address is 175 Crossing Blvd. 4th Floor Framingham MA 01702 MA

Concert Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Stock Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Roger D. Tung 2020 $581,967 - $1,011,657 $1,098,957 $320,082 $12,114 $3,024,777
Roger D. Tung 2019 $562,287 - $1,889,500 - $309,258 $11,304 $2,772,349
James V. Cassella 2020 $450,633 - $283,144 $306,708 $225,317 $15,408 $1,281,210
James V. Cassella 2019 $435,394 - $708,563 $319,397 $217,697 $13,988 $1,695,039
Nancy Stuart 2020 $444,530 - $455,212 $493,096 $177,812 $12,114 $1,582,764
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1367920/000136792021000022/a2021proxy.htm

What are Concert Pharmaceuticals, Inc's Past Insider Trades?

Concert Pharmaceuticals, Inc's most recent insider trade came on June 6, 2022 by Christi Heek Van who bought 10,526 units worth $50K . In the last 8 years, insiders at Concert Pharmaceuticals, Inc have sold an estimated value of $71.76M and bought an estimated value of $26.81M worth of shares. Insider trading is most common in June, with the busiest year in 2015 and 2018. The most active traders at the company are Nancy Stuart, Chief Operating Officer,  Roger Tung, Chief Executive Officer,  and Richard Aldrich, Director .

CONCERT PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1